Tempering antigen-presenting cells in multiple sclerosis

被引：12
作者：
Prod'homme, Thomas [1 ]
Zamvil, Scott S.
机构：
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
来源：
NATURE MEDICINE | 2008年 / 14卷 / 06期
关键词：
D O I：
10.1038/nm0608-614
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A variety of immune cell types contribute to disease in individuals with multiple sclerosis, an autoimmune condition of the central nervous system. Thomas Prod'homme and Scott Zamvil comment on the 'Bench to Bedside' approach, examining how recent basic research implicates the antigen-presenting cell in this disease. In our 'Bedside to Bench' column, Hans Link explores how recent clinical trials may bolster a mechanistic role for the B cell.
引用
收藏
页码：614 / 615
页数：3
相关论文
共 12 条
  • [1] Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
    Bielekova, B
    Goodwin, B
    Richert, N
    Cortese, I
    Kondo, T
    Afshar, G
    Gran, B
    Eaton, J
    Antel, J
    Frank, JA
    McFarland, HF
    Martin, R
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1167 - 1175
  • [2] Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis
    Fitzgerald, Denise C.
    Ciric, Bogoljub
    Touil, Tarik
    Harle, Heather
    Grammatikopolou, Julia
    Das Sarma, Jayasri
    Gran, Bruno
    Zhang, Guang-Xian
    Rostami, Abdolmohamad
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 179 (05) : 3268 - 3275
  • [3] The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
    Guo, Beichu
    Chang, Elmer Y.
    Cheng, Genhong
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (05) : 1680 - 1690
  • [4] Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
    Kappos, L
    Comi, G
    Panitch, H
    Oger, J
    Antel, J
    Conlon, P
    Steinman, L
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1176 - 1182
  • [5] Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity
    Krieg, Arthur M.
    Vollmer, Joerg
    [J]. IMMUNOLOGICAL REVIEWS, 2007, 220 : 251 - 269
  • [6] Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
    Prinz, Marco
    Schmidt, Hauke
    Mildner, Alexander
    Knobeloch, Klaus-Peter
    Hanisch, Uwe-Karsten
    Raasch, Jenni
    Merkler, Doron
    Detje, Claudia
    Gutcher, Ilona
    Mages, Joerg
    Lang, Roland
    Martin, Roland
    Gold, Ralf
    Becher, Burkhard
    Bruck, Wolfgang
    Kalinke, Ulrich
    [J]. IMMUNITY, 2008, 28 (05) : 675 - 686
  • [7] Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis
    Rudick, RA
    Ransohoff, RM
    Peppler, R
    Medendorp, SV
    Lehmann, P
    Alam, J
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (04) : 618 - 627
  • [8] A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
    Steinman, Lawrence
    [J]. NATURE MEDICINE, 2007, 13 (02) : 139 - 145
  • [9] IFN-β gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis
    Teige, I
    Treschow, A
    Teige, A
    Mattsson, R
    Navikas, V
    Leanderson, T
    Holmdahl, R
    Issazadeh-Navikas, S
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (09) : 4776 - 4784
  • [10] Interferons in multiple sclerosis: Ten years' experience
    Tourbah, Ayman
    Lyon-Caen, Olivier
    [J]. BIOCHIMIE, 2007, 89 (6-7) : 899 - 902
12